Navigation Links
Komen grant supports research into suspicious gene tied to breast cancer
Date:8/9/2010

Someone in the world is diagnosed with breast cancer every 23 seconds. It is the leading cause of cancer death worldwide among women and approximately 456,000 die from the disease each year. At The University of Texas Health Science Center at Houston (UTHealth), a scientist is taking aim at the molecular machinery behind this disease.

Armed with an award from the Susan G. Komen for the Cure, Catherine Denicourt, Ph.D., an assistant professor of integrative biology and pharmacology at the UTHealth Medical School, is studying a suspicious gene tied to increased risk of malignant breast cancer.

"This is innovative research that we hope will lead us to better, easier and more effective treatments for breast cancer," said Nancy G. Brinker, founder and CEO of Susan G. Komen for the Cure. "Susan G. Komen for the Cure has a tremendous urgency to deliver the cures more effectively, particularly for aggressive cancers that are so serious and difficult."

While the body is constantly replacing old cells with new, cancer occurs when cell growth spins out of control. It can lead to tumors that can shut down vital organs. Much research has focused on the genes that control cell growth. They are called tumor suppressor genes and aid in the production of the proteins that carry out this job.

Denicourt's research is focused on a tumor suppressor gene (p27kip1) that has been associated with aggressive breast cancer. "We're looking at non-genetic causes of abnormal cell division," Denicourt said. "This is a tumor suppressor. But when it moves from the nucleus to the cytoplasm it becomes a tumor promoter. If we can understand why this is happening, we may be able to develop drugs to prevent it."


'/>"/>

Contact: Robert Cahill
Robert.Cahill@uth.tmc.edu
713-500-3030
University of Texas Health Science Center at Houston
Source:Eurekalert  

Page: 1

Related biology news :

1. Exciting new companies at NJITs small biz incubator get 100K in grants
2. Broad Institute awarded major grant to bolster epigenomics research
3. Entertainment Software Association Foundation awards grant to FAS for immune attack
4. National Science Foundation grants Clemson professors award to develop nanoprobes
5. Dunn Foundation gives Rice $3M for collaborative research grants
6. National Science Foundation grant expands UMCES oyster research
7. Penn State receives new NASA astrobiology grant
8. BIO-key(R) Granted Additional Patent for Biometric Security Solution
9. FSU researchers discovery leads to $1.5 million grant, potential new treatment of liver fibrosis
10. Northwest climate change is target of $3.2M in grants to University of Oregon
11. UT Southwestern researcher awarded Gates Foundation grant for novel vaccine development
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Komen grant supports research into suspicious gene tied to breast cancer
(Date:8/12/2015)... 2015  New research unveiled at Black Hat ... to steal users, fingerprints. Information released today by ... scanners on mobile devices, making the security of ... on mobile devices, HYPR Corp. recently released a ... systems with strong cryptographic security. More information on ...
(Date:8/6/2015)... Calif. , Aug. 6, 2015  Today, ... will visit Crossmatch ™ to learn firsthand ... and protect data. Crossmatch is a world leader ... technologies and expertise are helping federal agencies and ... and security.   "The vast majority ...
(Date:8/5/2015)... , Aug. 5, 2015 The biosensors market ... in applications, penetration into newer sectors, and development of ... global biosensors space has seen the entry of multiple ... so far. (Photo - http://photos.prnewswire.com/prnh/20150805/255570 ) ... Analysis of the Global Biosensors Market ( ...
Breaking Biology News(10 mins):HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 2HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 3Rep. Honda to Visit Crossmatch in Redwood City 2Innovative Biosensors Incite Use in Non-Traditional Applications 2Innovative Biosensors Incite Use in Non-Traditional Applications 3Innovative Biosensors Incite Use in Non-Traditional Applications 4
... wheat ( Triticum aestivum ) is one of the "big ... consumed by people. Fully 35% of the world,s 7 billion ... international team of scientists, including a group from Cold Spring ... its full genome. The study reveals the evolution ...
... a surprise to hear that most adult entertainment club workers ... bartenders, waitresses and hostesses don,t have great medical benefits. ... repeated unwanted sexual advances and behavior. Add in the prevalence ... a perfect storm for unchecked health risks. To ...
... unique aroma signature of the durian revered as the ... the world,s foulest smelling food has uncovered several new ... ACS, Journal of Agricultural and Food Chemistry . ... food shops in the United States and elsewhere, has a ...
Cached Biology News:Bread wheat's large and complex genome is revealed 2Bread wheat's large and complex genome is revealed 3Rhode Island Hospital: Adult entertainment workers likely to benefit from health care intervention 2
(Date:8/31/2015)... and SHANGHAI , ... privately-held biopharmaceutical company developing next-generation antibiotics, today announced ... clinical study for its lead drug candidate MRX-I. ... treat drug-resistant bacteria such as MRSA and VRE, ... better tolerated therapeutic option than currently available oxazolidinone ...
(Date:8/31/2015)... Aug. 31, 2015 LabStyle Innovations Corp. ... Solution, today announced it recently closed a round ... be used to support the global rollout and ... mobile, cloud-based, diabetes management solution that includes novel ... blood glucose monitoring device, and for working capital ...
(Date:8/31/2015)... IL (PRWEB) , ... August 31, 2015 , ... ... (PGIs), as a high priority in the drug development approval process. Thus, innovator ... , This year, Regis Technologies, Inc., a Chicago-based CMO, has been hosting multiple ...
(Date:8/31/2015)... ... August 31, 2015 , ... There’s a new treatment option ... the first commercially available new FDA approved system in the last 14 years, and ... the high Amenorrhea (zero bleeding) rate of 66%, the high Patient Satisfaction rate of ...
Breaking Biology Technology:MicuRX Reports Positive Top-Line Results In Phase 2 Clinical Trial For Novel Antibiotic MRX-I In Complicated Skin And Soft Tissue Infections 2LabStyle Innovations Closes $2.5 Million Funding to Support Global Rollout of Dario Diabetes Management Solution 2LabStyle Innovations Closes $2.5 Million Funding to Support Global Rollout of Dario Diabetes Management Solution 3LabStyle Innovations Closes $2.5 Million Funding to Support Global Rollout of Dario Diabetes Management Solution 4Regis Shares Expert Advice on Impurities in Drug Development 2Regis Shares Expert Advice on Impurities in Drug Development 3U.S. FDA Approves Minerva Endometrial Ablation System 2U.S. FDA Approves Minerva Endometrial Ablation System 3
... Sept. 17 Synvista,Therapeutics, Inc. (Amex: SYI ) ... to the Company,s Web site http://www.synvista.com . The,text ... team at Synvista Therapeutics has made tremendous progress in ... and to redefine,the treatment of cardiovascular disease in diabetics ...
... Sigma-Aldrich Corporation,(Nasdaq: SIAL ) will be presenting ... September 24th at 8:30 AM ET at the Grand ... live audio broadcast over the,Internet available at http://ir.sigmaaldrich.com ... file. For the webcast on, http://ir.sigmaaldrich.com users will ...
... Alfacell Corporation,(Nasdaq: ACEL ) announced today ... of Oppenheimer & Co. as a financial advisor ... alternatives to enhance,shareholder value, including a possible sale ... not be limited to, strategic partnership,transactions., "Alfacell ...
Cached Biology Technology:Synvista Therapeutics Posts Letter to Stockholders on Web Site 2Synvista Therapeutics Posts Letter to Stockholders on Web Site 3Synvista Therapeutics Posts Letter to Stockholders on Web Site 4Synvista Therapeutics Posts Letter to Stockholders on Web Site 5Synvista Therapeutics Posts Letter to Stockholders on Web Site 6Alfacell Hires Advisors to Advance Strategic Alternatives 2Alfacell Hires Advisors to Advance Strategic Alternatives 3
Human Cell Line Slides...
... 2 Detection System combines the indirect ... principle and Signets unique formulation of ... and reliablility. Signet reagents will achieve ... and automated protocols. ,Signets USA Detection ...
... Level 2 Detection System combines the ... bonding principle and Signets unique formulation ... specificity and reliablility. Signet reagents will ... manual and automated protocols. ,Signets ...
Ideally suited for resolving DNA and RNA 10-1000 bases especially PCR products ranging from 100-1000 bp. Gelling temp. (4%) 27C Melting temperature 65C. EEO: 0.10 Rnase/Dnase: none detected...
Biology Products: